Mr. Suseck joined Impact Biomedical in 2023 and brings expertise in market strategy, commercialization and healthcare leadership, helping to scale operations at Impact. He became COO of DSS BioHealth Holdings Inc., a subsidiary of DSS, Inc., in 2020. Prior to this Mr. Suseck served as the CEO of Vivacitas Oncology Inc., where he led company strategy, clinical development, operations, licensing, acquisitions and financing.
He also served as President of global sales and marketing at Helius Medical Technologies Inc. Mr. Suseck received his undergraduate degree in economics from Rutgers University, with minors in education and philosophy. He completed the Executive Management Program in residence at the University of Michigan Business School.
Get the latest news delivered to your inbox
